A detailed history of Voya Investment Management LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 24,627 shares of PSTX stock, worth $71,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,627
Previous 22,507 9.42%
Holding current value
$71,418
Previous $71,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.0 - $3.46 $4,240 - $7,335
2,120 Added 9.42%
24,627 $71,000
Q1 2024

May 15, 2024

SELL
$2.76 - $4.13 $133,283 - $199,441
-48,291 Reduced 68.21%
22,507 $71,000
Q4 2023

Feb 14, 2024

BUY
$1.83 - $3.51 $78,267 - $150,119
42,769 Added 152.59%
70,798 $237,000
Q2 2023

Aug 14, 2023

BUY
$1.66 - $3.4 $46,528 - $95,298
28,029 New
28,029 $49,000
Q2 2022

Aug 15, 2022

SELL
$1.87 - $5.0 $21,387 - $57,185
-11,437 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$6.23 - $7.6 $14,802 - $18,057
-2,376 Reduced 17.2%
11,437 $78,000
Q3 2021

Nov 15, 2021

SELL
$7.09 - $10.71 $708,461 - $1.07 Million
-99,924 Reduced 87.86%
13,813 $101,000
Q2 2021

Aug 16, 2021

SELL
$7.96 - $10.07 $26,260 - $33,220
-3,299 Reduced 2.82%
113,737 $1.14 Million
Q1 2021

May 17, 2021

SELL
$8.51 - $11.91 $1.16 Million - $1.62 Million
-136,124 Reduced 53.77%
117,036 $1.12 Million
Q4 2020

Feb 16, 2021

SELL
$8.29 - $11.7 $197,434 - $278,647
-23,816 Reduced 8.6%
253,160 $2.78 Million
Q3 2020

Nov 16, 2020

BUY
$8.09 - $16.25 $2.24 Million - $4.5 Million
276,976 New
276,976 $2.46 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $249M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.